Several microRNAs (miRNAs) that are involved in the regulation of cellular metabolism or immune processes are deregulated in patients with rheumatic diseases, such as rheumatoid arthritis or osteoarthritis. These small inhibitory molecules offer considerable potential for the treatment of these disorders, but a multidisciplinary approach is needed to limit their potential adverse effects through, for example, improved specificity and delivery.
- Rita Vicente
- Danièle Noël
- Christian Jorgensen